Skip to Content

Eurofins Scientific SE ERFSF

Morningstar Rating
$52.13 −0.48 (0.91%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ERFSF is trading within a range we consider fairly valued.
Price
$52.41
Fair Value
$44.21
Uncertainty
High
1-Star Price
$42.37
5-Star Price
$39.69
Economic Moat
Fmxsjk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ERFSF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$52.61
Day Range
$51.8055.79
52-Week Range
$44.6170.00
Bid/Ask
$50.89 / $56.04
Market Cap
$9.96 Bil
Volume/Avg
79 / 2,685

Key Statistics

Price/Earnings (Normalized)
16.70
Price/Sales
1.46
Dividend Yield (Trailing)
1.04%
Dividend Yield (Forward)
1.04%
Total Yield
1.55%

Company Profile

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its areas of business activity are food, feed, and environmental testing ("Life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
61,798

Competitors

Valuation

Metric
ERFSF
CRL
BVI
Price/Earnings (Normalized)
16.7021.3220.52
Price/Book Value
2.223.066.22
Price/Sales
1.462.712.07
Price/Cash Flow
9.4314.6114.18
Price/Earnings
ERFSF
CRL
BVI

Financial Strength

Metric
ERFSF
CRL
BVI
Quick Ratio
1.341.171.67
Current Ratio
1.451.751.67
Interest Coverage
4.184.958.40
Quick Ratio
ERFSF
CRL
BVI

Profitability

Metric
ERFSF
CRL
BVI
Return on Assets (Normalized)
5.44%6.50%8.25%
Return on Equity (Normalized)
13.87%15.17%31.39%
Return on Invested Capital (Normalized)
7.66%9.55%12.79%
Return on Assets
ERFSF
CRL
BVI
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
KvgssrvxhHkr$209.2 Bil
Danaher Corp
DHR
SpwrldftnpClgwgn$182.7 Bil
IQVIA Holdings Inc
IQV
DmvvjkyHvyznnc$40.8 Bil
IDEXX Laboratories Inc
IDXX
SbgfxblfsRtwplf$40.7 Bil
Agilent Technologies Inc
A
DjlkftcdgpZzl$38.6 Bil
Mettler-Toledo International Inc
MTD
WqxxdrwmFcyqyx$29.0 Bil
Icon PLC
ICLR
TjfrtvkdYhzncwy$27.8 Bil
Illumina Inc
ILMN
ThwywzkhvQtqxvh$18.5 Bil
Waters Corp
WAT
LdbyrlzsnMdkf$17.9 Bil
Labcorp Holdings Inc
LH
DkrjtytmHnptwwd$17.4 Bil

Sponsor Center